Genital infections due to the human papillomavirus

被引:20
作者
Sendagorta-Cudos, Elena [1 ]
Burgos-Cibrian, Joaquin [2 ]
Rodriguez-Iglesias, Manuel [3 ]
机构
[1] Hosp Univ La Paz, Serv Dermatol, Madrid, Spain
[2] Hosp Univ Vall dHebron, Serv Enfermedades Infecciosas, Barcelona, Spain
[3] Hosp Univ Puerta del Mar, Serv Microbiol, Cadiz, Spain
来源
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA | 2019年 / 37卷 / 05期
关键词
Papillomavirus; Condyloma; Vaccines; HPV VACCINE; ADVISORY-COMMITTEE; ANOGENITAL WARTS; DOUBLE-BLIND; WOMEN; RISK; EFFICACY; LESIONS; MEN; RECOMMENDATIONS;
D O I
10.1016/j.eimc.2019.01.010
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The Human Papillomavirus (HPV) is a double-stranded DNA virus, with more than 200 different genotypes having been identified. This infection is considered the most common sexually transmitted infection (STI), and it is the cause of a significant number of diseases, both benign lesions (anogenital condylomas) and pre-malignant lesions and different cancers. The diagnosis of the infection is performed by molecular techniques based on the detection of viral DNA, the mRNA of oncogenic proteins and cellular alteration caused by the infection. Although there is no consensus regarding the best treatment, this should be individualised, and there are different options with ablative treatments being more effective but with greater recurrences, and immunomodulatory treatments being less effective in the short term but with fewer recurrences. Among the preventive strategies, vaccination against HPV is the best strategy against anogenital neoplasms and warts, its maximum effectiveness being when it is administered prior to exposure to HPV. (C) 2019 Elsevier Espana, S.L.U. and Sociedad Espanola de Enfermedades Infecciosas y Microbiologia Clinica. All rights reserved.
引用
收藏
页码:324 / 334
页数:11
相关论文
共 63 条
[1]   Anal squamous intralepithelial lesions and condyloma in HIV-infected heterosexual men, homosexual men and women:: prevalence and associated factors [J].
Abramowitz, Laurent ;
Benabderrahmane, Dalila ;
Ravaud, Philippe ;
Walker, Francine ;
Rioux, Christophe ;
Lestin, Christine ;
Bouvet, Elisabeth ;
Soule, Jean-Claude ;
Leport, Catherine ;
Duval, Xavier .
AIDS, 2007, 21 (11) :1457-1465
[2]  
Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P626
[3]  
[Anonymous], MMWR MORB MORTAL WKL
[4]  
[Anonymous], GEN HPV INF FACT SHE
[5]  
[Anonymous], INT J CANC
[6]   Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening? [J].
Arbyn, M. ;
Snijders, P. J. F. ;
Meijer, C. J. L. M. ;
Berkhof, J. ;
Cuschieri, K. ;
Kocjan, B. J. ;
Poljak, M. .
CLINICAL MICROBIOLOGY AND INFECTION, 2015, 21 (09) :817-826
[7]  
Arbyn M, 2018, COCHRANE DB SYST REV, V5, DOI DOI 10.1002/14651858.CD009069.PUB3.29740819
[8]   VALGENT: A protocol for clinical validation of human papillomavirus assays [J].
Arbyn, Marc ;
Depuydt, Christophe ;
Benoy, Ina ;
Bogers, Johannes ;
Cuschieri, Kate ;
Schmitt, Markus ;
Pawlita, Michael ;
Geraets, Daan ;
Heard, Isabelle ;
Gheit, Tarik ;
Tommasino, Massimo ;
Poljak, Mario ;
Bonde, Jesper ;
Quint, Wim .
JOURNAL OF CLINICAL VIROLOGY, 2016, 76 :S14-S21
[9]   Significant Decrease in the Incidence of Genital Warts in Young Danish Women After Implementation of a National Human Papillomavirus Vaccination Program [J].
Baandrup, Louise ;
Blomberg, Maria ;
Dehlendorff, Christian ;
Sand, Carsten ;
Andersen, Klaus K. ;
Kjaer, Susanne K. .
SEXUALLY TRANSMITTED DISEASES, 2013, 40 (02) :130-135
[10]  
Baker David A, 2011, Infect Dis Obstet Gynecol, V2011, P806105, DOI 10.1155/2011/806105